We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · January 04, 2021

The Effects of Dapagliflozin, Metformin, or Exercise on Glycaemic Variability in Overweight or Obese Individuals With Prediabetes

Diabetologia

 

Additional Info

Diabetologia
The Effects of Dapagliflozin, Metformin, or Exercise on Glycaemic Variability in Overweight or Obese Individuals With Prediabetes (the PRE-D Trial): A Multi-Arm, Randomised, Controlled Trial
Diabetologia 2021 Jan 01;64(1)42-55, K Færch, MB Blond, L Bruhn, H Amadid, D Vistisen, KKB Clemmensen, CTR Vainø, C Pedersen, M Tvermosegaard, TF Dejgaard, K Karstoft, M Ried-Larsen, F Persson, ME Jørgensen

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading